Wall Street really needs/wants to see EECP/equipment side contribute more to both top and bottom line. the trend the last three quarters has been very positive for EECP and if that continues in 4Q13 and continues the exponential increase - we may finally see a sustainable breakout and real, long term price increase.
the $100MM question is whether or not they get a special consideration with CMS. seems like a no brainer with the wealth of third party peer review and trial results since original PEECH results. all of the major detractions negating major change in angina and CHF coverage after PEECH have been definitively answered and put to bed. this warrants that consideration and a massive change in line with the recent EU change in coverage/status.
Recent VASO News
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 03/06/2024 09:58:30 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 12/11/2023 07:10:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:00:38 PM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM